Everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction: a randomized controlled trial : Coronary Artery Disease

Journal Logo

Original Research in CAD

Everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction: a randomized controlled trial

Eriksen, Erlenda,b; Neghabat, Omeedc; Saeed, Sahraia; Herstad, Jona; Nordrehaug, Jan Erikb; Tuseth, Vegarda,b; Holm, Niels Ramsingc; Holck, Emil Nielsenc; Sejr-Hansen, Martinc; Maule, Camilla Foxc; Barkholt, Trine Ørhøjc; Andreasen, Lene Nyhusc; Christiansen, Evald Højc; Bleie, Øyvinda

Author Information
Coronary Artery Disease 34(1):p 1-10, January 2023. | DOI: 10.1097/MCA.0000000000001202

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid